Status: Recruiting
Study of the Role of Genetic Modifiers in Hemoglobinopathies
This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).
Participants needed: 30,000
Trial details
Age: 2+Biological sex: AllType: ObservationalSponsor: Cyprus Institute of Neurology and GeneticsUpdated: Mar 20, 2024Locations: 26
Eligibility criteria
Clinical diagnosis of an inherited hemoglobinopathy, including sickle cell disea... [+2]
Patients treated with stem cell transplantation or genetic therapy. [+2]